Afatinib for the treatment of advanced non-small-cell lung cancer

Author： Genova Carlo   Rijavec Erika   Barletta Giulia   Burrafato Giovanni   Biello Federica   Dal Bello Maria Giovanna   Coco Simona   Truini Anna   Alama Angela   Boccardo Francesco   Grossi Francesco  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.6, 2014-04, pp. : 889-903

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Axitinib for the treatment of advanced non-small-cell lung cancer

By King Judy W  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 765-773

Informa Healthcare

Access to resources Recommend Favorite

Vandetanib for the treatment of non-small-cell lung cancer

By Wong Hui-li   de Boer Richard H  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2271-2278

Informa Healthcare

Access to resources Recommend Favorite

The Vx 001 [TERT572Y] vaccine has shown promise in the treatment of advanced non-small-cell lung cancer

By  

Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Bevacizumab: a potential new option in the treatment of advanced breast or non-small-cell lung cancer

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 9, 2006-09 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review

By Bongers Mathilda L.  

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 17-34

Adis International

Access to resources Recommend Favorite